Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01156844 · ClinicalTrials.gov registry record · Phase 2
Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol
A Phase 2 study, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 191
- Enrollment target
NCT01156844: Completed Phase 2 study, sponsored by Novartis Pharmaceuticals.
NCT01156844 is a Phase 2 study that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 191 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01156844, a Phase 2 study, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 191 participants
- Enrollment target
Study Summary
This study assessed the bronchodilator efficacy of three different regimens of indacaterol in patients with asthma
Primary Outcome
Spirometry was conducted according to internationally accepted standards. Trough FEV1 values were calculated as the mean of the 23.17 hours and 23.75 hours post morning dose FEV1 measurements. Analysis of covariance model was used with baseline FEV1 as a continuous covariate.
Interventions
- DRUG Indacaterol
- DRUG Placebo to Indacaterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2010-03 |
| Phase | Phase 2 |
What the finished NCT01156844 record still lists
NCT01156844 is an interventional study that assigns participants to a tested intervention. The registered 191 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% higher).
The record links to 0 conditions, and to 2 interventions - of which Indacaterol is the first listed.
NCT01156844 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01156844 about?
NCT01156844 is a clinical study titled "Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol". This study assessed the bronchodilator efficacy of three different regimens of indacaterol in patients with asthma
What is the current status of trial NCT01156844?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 191 participants. The study started on 2010-03.
What interventions are being tested in trial NCT01156844?
The interventions under investigation include: Indacaterol (DRUG), Placebo to Indacaterol (DRUG).
Who is sponsoring clinical trial NCT01156844?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01156844's enrollment target sits among peer trials
191 353rd of 2000 higher than 1,648 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04621435 · 191 participants · Phase 1
Imaging of Solid Tumors Using FAP-2286
- NCT06810544 · 191 participants · Phase 1
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia